The Effects of Endotracheal Suctioning on Pain and Serum Markers

Last updated: February 12, 2025
Sponsor: Loma Linda University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Soft Tissue Infections

Pneumonia

Covid-19

Treatment

endotracheal tube suctioning

Clinical Study ID

NCT06692400
5240556
  • Ages > 18
  • All Genders

Study Summary

The goal of this experimental study is to understand if endotracheal tube (ETT) suctioning increases pain and causes stress on the body in intubated adult ICU patients. These patients are already on ventilators, which means they need suctioning to keep their airways clear, but this procedure may be uncomfortable and cause stress.

The main questions this study aims to answer are:

Does ETT suctioning raise pain levels as measured by the Critical-Care Pain Observation Tool (CPOT)? Does ETT suctioning increase certain chemicals in the blood (hypoxanthine, xanthine, and uric acid) that show stress and lack of oxygen in the body? Researchers will compare patients who have ETT suctioning (intervention group) with those who do not have suctioning during the study period (control group) to see if there are differences in pain and blood markers of stress.

Participants will:

Have pain measured before and after suctioning using the CPOT. Have blood samples taken from an existing line at three time points: 5 minutes before, 5 minutes after, and 30 minutes after suctioning.

Provide demographic information (like age, gender, and diagnosis) from medical records.

This research will help improve how pain is managed for ICU patients who cannot speak for themselves, potentially leading to better pain relief methods in the future.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Adults (aged 18 years and older)

  • Current diagnosis of flu, pneumonia, COVID, or sepsis

  • Intubated and receiving mechanical ventilation.

  • Have arterial lines placed

  • Require endotracheal suctioning as part of their care

Exclusion

Exclusion Criteria:

  • Patients receiving neuromuscular blocking agents

  • Contraindications for blood draws (hemoglobin levels below 8.0 g/dL; Jehovah'sWitness)

Study Design

Total Participants: 110
Treatment Group(s): 1
Primary Treatment: endotracheal tube suctioning
Phase:
Study Start date:
January 30, 2025
Estimated Completion Date:
January 31, 2026

Connect with a study center

  • Loma Linda University Medical Center Troesh Medical Campus

    Loma Linda, California 92354
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.